Genetic Technologies (ASX:GTG) announces the execution of a strategic joint sales & marketing agreement with US based Wellworks for You. As part of the agreement, Wellworks will incorporate the geneType portfolio of tests into its wellness solutions for organizations and businesses across the U.S, providing direct access to more than two million personnel | ASX announcement: https://app.sharelinktechnologies.com/announcement/asx/2c675d530c613b5824ac07a924953524
BlinkLab (ASX:BB1) has initiated a clinical study in partnership with US based Turning Pointe Autism Foundation.
The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.
BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism.
Read the ASX announcement:...
The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.
BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism.
Read the ASX announcement:...
1
Carly's (ASX:CL8) CEO, Chris Noone, sits down with Russell Katz, the host of The Stock Network's StockTales podcast to discuss the outlook of car subscription in Australia and how the company is planning on bringing EV cars to the masses.Listen to the podcast on
Spotify: Spotify
Watch the interview on TSN's YouTube: https://youtu.be/BbjP4gfbc7g
Spotify: Spotify
Watch the interview on TSN's YouTube: https://youtu.be/BbjP4gfbc7g
OncoSil Medical (ASX:OSL) reveals results of a study showing that the addition of OncoSil™ to systemic chemotherapy significantly increases the vascularity of the primary pancreatic tumors and at the same time results in a significant decrease in the size of the tumours.
- This is believed to be the first study in humans demonstrating that the poor vascularity of pancreatic cancer tumors can be increased
- This may consequently increase the concentration of chemotherapy agents within the tumor ...
- This is believed to be the first study in humans demonstrating that the poor vascularity of pancreatic cancer tumors can be increased
- This may consequently increase the concentration of chemotherapy agents within the tumor ...
Authentication and consumer engagement technology group YPB Group (ASX: YPB) March quarter report has highlighted recent achievements and says it remains "very optimistic as to 2024 proving our best year yet by a considerable margin" | ASX announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02801215-6A1205218 #
YPB
YPB
Lithium Energy (ASX:LEL) announces the sale of the Solaroz Lithium Project for A$97 million by CNGR Netherlands New Energy Technology B.V.
- CNGR is one of the world’s largest producers of precursor materials for leading companies in the battery materials supply chain.
- CNGR will purchase Lithium Energy's 90% interest in the Solaroz Lithium Brine Project in Argentina for US$63 Million (~A$97 Million) cash.
Read the ASX announcement: https://wcsecure.weblink.com.au/pdf/LEL/02801779.pdf #
LEL #...
- CNGR is one of the world’s largest producers of precursor materials for leading companies in the battery materials supply chain.
- CNGR will purchase Lithium Energy's 90% interest in the Solaroz Lithium Brine Project in Argentina for US$63 Million (~A$97 Million) cash.
Read the ASX announcement: https://wcsecure.weblink.com.au/pdf/LEL/02801779.pdf #
LEL #...
Star Entertainment (ASX:SGR) appoints Anne Ward as Chairman of the Board, effective immediately, while Mr Foster will step down and remain on the Board of The Star and continue his executive responsibilities | ASX announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02799903-2A1519722 #
SGR #TheStarEntertainment
SGR #TheStarEntertainment
1
AML3D (ASX:AL3) has signed a contract with the Australian Government Defence Science and Technology Group to provide components for testing in marine applications.
➡️The A$0.24 million contract requires AML3D to 3D metal print two representative marine components using a Nickel Aluminium Bronze alloy and high strength duplex steel alloy.
➡️Manufacturing of the test components will commence immediately at AML3D’s facility in Adelaide for delivery during FY24.
Read the announcement: https://www.investi.com.au/api/announcements/al3/509a788b-3f6.pdf
➡️The A$0.24 million contract requires AML3D to 3D metal print two representative marine components using a Nickel Aluminium Bronze alloy and high strength duplex steel alloy.
➡️Manufacturing of the test components will commence immediately at AML3D’s facility in Adelaide for delivery during FY24.
Read the announcement: https://www.investi.com.au/api/announcements/al3/509a788b-3f6.pdf